Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effective questionnaire-based prediction models for type 2 diabetes across several ethnicities: a model development and validation study.
Kokkorakis M, Folkertsma P, van Dam S, Sirotin N, Taheri S, Chagoury O, Idaghdour Y, Henning RH, Forte JC, Mantzoros CS, de Vries DH, Wolffenbuttel BHR. Kokkorakis M, et al. Among authors: mantzoros cs. EClinicalMedicine. 2023 Sep 25;64:102235. doi: 10.1016/j.eclinm.2023.102235. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37936659 Free PMC article.
Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study.
Kouvari M, Valenzuela-Vallejo L, Guatibonza-Garcia V, Polyzos SA, Deng Y, Kokkorakis M, Agraz M, Mylonakis SC, Katsarou A, Verrastro O, Markakis G, Eslam M, Papatheodoridis G, George J, Mingrone G, Mantzoros CS. Kouvari M, et al. Among authors: mantzoros cs. Metabolism. 2023 Oct;147:155666. doi: 10.1016/j.metabol.2023.155666. Epub 2023 Jul 30. Metabolism. 2023. PMID: 37527759
The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter study.
Kouvari M, Mylonakis SC, Katsarou A, Valenzuela-Vallejo L, Guatibonza-Garcia V, Kokkorakis M, Verrastro O, Angelini G, Markakis G, Eslam M, George J, Papatheodoridis G, Mingrone G, Mantzoros CS. Kouvari M, et al. Among authors: mantzoros cs. Diabetes Res Clin Pract. 2023 Sep;203:110870. doi: 10.1016/j.diabres.2023.110870. Epub 2023 Aug 9. Diabetes Res Clin Pract. 2023. PMID: 37567510
Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery.
Kokkorakis M, Katsarou A, Katsiki N, Mantzoros CS. Kokkorakis M, et al. Among authors: mantzoros cs. Metabolism. 2023 Nov;148:155689. doi: 10.1016/j.metabol.2023.155689. Epub 2023 Sep 7. Metabolism. 2023. PMID: 37689110 Review.
Recent research advances in metabolism, clinical and experimental.
Boutari C, Kokkorakis M, Stefanakis K, Valenzuela-Vallejo L, Axarloglou E, Volčanšek Š, Chakhtoura M, Mantzoros CS. Boutari C, et al. Among authors: mantzoros cs. Metabolism. 2023 Dec;149:155722. doi: 10.1016/j.metabol.2023.155722. Epub 2023 Nov 4. Metabolism. 2023. PMID: 37931873 No abstract available.
Obesity and diabetes.
Boutari C, DeMarsilis A, Mantzoros CS. Boutari C, et al. Among authors: mantzoros cs. Diabetes Res Clin Pract. 2023 Aug;202:110773. doi: 10.1016/j.diabres.2023.110773. Epub 2023 Jun 23. Diabetes Res Clin Pract. 2023. PMID: 37356727 Review.
620 results